RecruitingPhase 1 / Phase 2NCT03850574
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Aptose Biosciences Inc.
Huston, TX · +14 more sites